ClinicalTrials.gov
public full text
Public Domain
Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis
An open prospective study with multiple (every 6-12 months) intrathecal or intravenous injections of autologous MSC in patients with progressive forms of MS (secondary progressive, primary progressive or relapsing-progressive), who failed to respond to first and second lines of immunomodulatory treatments and deteriorated (at least 0.5 degree in the EDSS scale) during the year preceding their inclusion to our study or had at least one major relapse without sufficient recovery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Validity and Reliability of the Modified Four Square Step Test in Multiple Sclerosis Patients#1095678
- Multiple Sclerosis and Heavy Progressive Resistance Training#870040
- Follow-up of Persons With Multiple Sclerosis#1074876
- Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis#846830
- Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis#915608
Record · ID 857917
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive